Corcept Therapeutics Incorporated Stock Filter Stocks by Fundamentals
| CORT Stock | USD 22.66 0.34 1.48% |
Corcept Therapeutics Incorporated fundamentals help investors to digest information that contributes to Corcept Therapeutics' financial success or failures. It also enables traders to predict the movement of Corcept Stock. The fundamental analysis module provides a way to measure Corcept Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Corcept Therapeutics stock.
Corcept | Shares Owned by Institutions |
Corcept Therapeutics Institutional Holders
Institutional Holdings refers to the ownership stake in Corcept Therapeutics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Corcept Therapeutics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Corcept Therapeutics' value.| Shares | D. E. Shaw & Co Lp | 2023-09-30 | 1.5 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1.3 M | Arrowstreet Capital Limited Partnership | 2023-12-31 | 1.1 M | Northern Trust Corp | 2023-12-31 | 1.1 M | Goldman Sachs Group Inc | 2023-12-31 | 1.1 M | Charles Schwab Investment Management Inc | 2023-12-31 | 900.4 K | Man Group Plc | 2023-12-31 | 826.1 K | Bank Of New York Mellon Corp | 2023-12-31 | 772.8 K | Norges Bank | 2023-12-31 | 757.5 K | Blackrock Inc | 2023-12-31 | 16.4 M | Vanguard Group Inc | 2023-12-31 | 9.5 M |
Corcept Fundamentals
| Return On Equity | 0.21 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.22 % | ||||
| Operating Margin | 0.23 % | ||||
| Current Valuation | 2.03 B | ||||
| Shares Outstanding | 103.84 M | ||||
| Shares Owned By Insiders | 11.41 % | ||||
| Shares Owned By Institutions | 83.60 % | ||||
| Number Of Shares Shorted | 21.33 M | ||||
| Price To Earning | 30.07 X | ||||
| Price To Book | 4.82 X | ||||
| Price To Sales | 5.06 X | ||||
| Revenue | 482.38 M | ||||
| Gross Profit | 396.47 M | ||||
| EBITDA | 109.64 M | ||||
| Net Income | 106.14 M | ||||
| Cash And Equivalents | 370.09 M | ||||
| Cash Per Share | 3.45 X | ||||
| Total Debt | 151 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 8.54 X | ||||
| Book Value Per Share | 4.90 X | ||||
| Cash Flow From Operations | 127.04 M | ||||
| Short Ratio | 23.77 X | ||||
| Earnings Per Share | 0.95 X | ||||
| Price To Earnings To Growth | 0.61 X | ||||
| Target Price | 42.8 | ||||
| Number Of Employees | 352 | ||||
| Beta | 0.48 | ||||
| Market Capitalization | 2.43 B | ||||
| Total Asset | 621.52 M | ||||
| Retained Earnings | 402.53 M | ||||
| Working Capital | 354.13 M | ||||
| Current Asset | 48.98 M | ||||
| Current Liabilities | 20.88 M | ||||
| Net Asset | 621.52 M |
About Corcept Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Corcept Therapeutics Incorporated's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Corcept Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Corcept Therapeutics Incorporated based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Corcept Therapeutics Investors Sentiment
The influence of Corcept Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Corcept. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Corcept Therapeutics' public news can be used to forecast risks associated with an investment in Corcept. The trend in average sentiment can be used to explain how an investor holding Corcept can time the market purely based on public headlines and social activities around Corcept Therapeutics Incorporated. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Corcept Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Corcept Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Corcept Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Corcept Therapeutics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Corcept Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Corcept Therapeutics' short interest history, or implied volatility extrapolated from Corcept Therapeutics options trading.
Pair Trading with Corcept Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Corcept Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corcept Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Corcept Stock
| 0.64 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.55 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
| 0.55 | DRTS | Alpha Tau Medical Financial Report 28th of May 2024 | PairCorr |
| 0.54 | DMTK | DermTech Financial Report 2nd of May 2024 | PairCorr |
| 0.48 | ME | 23Andme Holding | PairCorr |
The ability to find closely correlated positions to Corcept Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Corcept Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Corcept Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Corcept Therapeutics Incorporated to buy it.
The correlation of Corcept Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Corcept Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Corcept Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Corcept Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Corcept Therapeutics Piotroski F Score and Corcept Therapeutics Altman Z Score analysis. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Corcept Stock analysis
When running Corcept Therapeutics' price analysis, check to measure Corcept Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corcept Therapeutics is operating at the current time. Most of Corcept Therapeutics' value examination focuses on studying past and present price action to predict the probability of Corcept Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corcept Therapeutics' price. Additionally, you may evaluate how the addition of Corcept Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is Corcept Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Corcept Therapeutics. If investors know Corcept will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Corcept Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.995 | Earnings Share 0.95 | Revenue Per Share 4.658 | Quarterly Revenue Growth 0.314 | Return On Assets 0.1113 |
The market value of Corcept Therapeutics is measured differently than its book value, which is the value of Corcept that is recorded on the company's balance sheet. Investors also form their own opinion of Corcept Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Corcept Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Corcept Therapeutics' market value can be influenced by many factors that don't directly affect Corcept Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Corcept Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Corcept Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Corcept Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.